Quick Answer
Cellyan Biotechnology Co., Ltd reported Total Assets of $9.42 million for fiscal year 2025.
Cellyan Biotechnology Co., Ltd — Key Financials by Year
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Assets | $9.42M +8.7% |
$8.67M | — |
| Gross Profit | $2.42M -32.1% |
$3.56M +29.9% |
$2.74M |
- Cellyan Biotechnology Co., Ltd reported Total Assets of $9.42 million for fiscal year 2025.
- Cellyan Biotechnology Co., Ltd showed an increase of +8.7% in Total Assets compared to the prior fiscal year.
- Cellyan Biotechnology Co., Ltd reported Gross Profit of $2.42 million for fiscal year 2025.
- Cellyan Biotechnology Co., Ltd showed a decrease of -32.1% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: